title: First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child.
authors.affiliation: Department of Paediatrics, Klinikum rechts der Isar, Technische Universität München; Laboratory of Functional Genomics and Transplantation Biology, Children's Cancer Research Center, Paediatric Oncology and Roman Herzog Comprehensive Cancer Center, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
authors.forename: T G P
authors.initials: TGP
authors.lastname: Grunewald
authors.affiliation: Department of Paediatrics, Klinikum rechts der Isar, Technische Universität München.
authors.forename: L
authors.initials: L
authors.lastname: Damke
authors.affiliation: Department of Haematology, Federal Clinical Research Center for Paediatric Haematology, Oncology and Immunology, Moscow.
authors.forename: M
authors.initials: M
authors.lastname: Maschan
authors.affiliation: Department of Haematology-1, Russian Children's Clinical Hospital, Moscow.
authors.forename: U
authors.initials: U
authors.lastname: Petrova
authors.affiliation: Department of Haematology, Yaroslavl Regional Children's Hospital, Yaroslavl.
authors.forename: O
authors.initials: O
authors.lastname: Surianinova
authors.affiliation: Department of Haematology, Yaroslavl Regional Children's Hospital, Yaroslavl.
authors.forename: A
authors.initials: A
authors.lastname: Esipenko
authors.affiliation: Department of Pathology, Federal Clinical Research Center for Paediatric Haematology, Oncology and Immunology, Moscow, Russian Federation.
authors.forename: D
authors.initials: D
authors.lastname: Konovalov
authors.affiliation: Department of Paediatrics, Klinikum rechts der Isar, Technische Universität München.
authors.forename: U
authors.initials: U
authors.lastname: Behrends
authors.affiliation: Department of Pathology, Klinikum Schwabing.
authors.forename: J
authors.initials: J
authors.lastname: Schiessl
authors.affiliation: Department of Radiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Wörtler
authors.affiliation: Department of Paediatrics, Klinikum rechts der Isar, Technische Universität München; Laboratory of Functional Genomics and Transplantation Biology, Children's Cancer Research Center, Paediatric Oncology and Roman Herzog Comprehensive Cancer Center, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Burdach
authors.affiliation: Department of Paediatrics, Klinikum rechts der Isar, Technische Universität München. Electronic address: irene.teichert-luettichau@lrz.tum.de.
authors.forename: I
authors.initials: I
authors.lastname: von Luettichau
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002648:Child; D005240:Feasibility Studies; D006801:Humans; D008202:Lymphangioma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab